Founded in 2010 in San Francisco, ReThink Medical's solution changes the reactive nature of health care specific to heart failure by drastically reducing costs and significantly improving the quality of life for the patients affected by this disease. ReThink's focus is to disrupt the standard of care that costs the US over $30 billion and affects more than 5 million people in the US annually.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/01/17 | $3,000,000 | Series A |
Emergent Medical Partners Launch Capital Norwich Ventures | undisclosed |
